ArticleJournal of clinical laboratory analysis2026
Development and Validation of a Nomogram Based on Red Blood Cell and Reticulocyte Parameters for Differentiating Thalassemia Trait From Iron Deficiency Anemia.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThalassemia trait (TT) and iron deficiency anemia (IDA) are the most common causes of microcytic hypochromic anemia with overlapping hematological features, complicating differential diagnosis. This study developed and internally validated a nomogram incorporating red blood cell (RBC) and reticulocyte parameters to preliminarily distinguish TT from IDA.
methodsA retrospective cohort of 517 patients (320 IDA, 197 TT) was randomly divided into training (n = 361) and validation (n = 156) cohorts at a 7:3 ratio using stratified random sampling according to diagnostic group. RBC parameters (RBC count, MCV, MCH) and reticulocyte indices (RET%, IRF, LFR, MFR, HFR) were collected. LASSO regression identified key variables, followed by multivariate logistic regression. Model performance was evaluated using ROC curves, calibration plots, and decision curve analysis (DCA).
resultsLASSO regression selected four predictors: RBC count, MCV, RET%, and HFR. Multivariate analysis showed elevated MCV (p < 0.001), RET% (p < 0.001), and HFR (p < 0.001) were associated with IDA, while elevated RBC count (p < 0.001) predicted TT. The nomogram achieved excellent discrimination with AUC of 0.900 in training and 0.904 in validation cohorts. Calibration plots showed good agreement and DCA suggested potential clinical net benefit across threshold probabilities of 7%-96% (training) and 5%-97% (validation).
conclusionsThis nomogram integrating RBC count, MCV, RET%, and HFR showed promising performance for the preliminary differentiation of TT from IDA and may serve as a practical, noninvasive screening aid for risk stratification and prioritization of confirmatory testing. It should not be used as a substitute for hemoglobin electrophoresis, thalassemia genetic testing, or iron studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.